Has Jeffrey Bezier, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,356 in general payments to Jeffrey Bezier, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Bezier, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Bezier, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Bezier, MD

Ophthalmology · Brookville, PANPI 1396747523

Payments from drug & device makers

$2,356in general payments, 2019–2025

Across 92 payments — averaging $25.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$1K
Notal Vision, Inc.$565
Genentech USA, Inc.$180
Alimera Sciences, Inc.$130
Rayner Intraocular Lenses Limited$44
Apellis Pharmaceuticals, Inc.$35
plus $130 from 6 others

What the payments were for

Food & beverage$2,34499%
Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	64	$1,273
Notal Vision, Inc.	1	$565
Genentech USA, Inc.	7	$180
Alimera Sciences, Inc.	8	$130
Rayner Intraocular Lenses Limited	2	$44
Apellis Pharmaceuticals, Inc.	2	$35
Novartis	2	$32
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$27
Harrow Eye, LLC	1	$22
Sun Pharmaceutical Industries Inc.	1	$21
Coopervision Inc.	1	$16
Kala Pharmaceuticals, Inc.	1	$13

How this compares

$2,356 in reported general payments places this provider in the 60th percentile of 920 ophthalmology providers in Pennsylvania.

See all ophthalmology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$1,291,020

Medicare patients

888

Services billed

12,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	66	$2,609
Tobramycin-DexamethasoneTobramycin/Dexamethasone	35	$2,051
Latanoprost	52	$411
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	11	$143
Timolol Maleate	11	$65

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Brookville

David AlmeidaErie$6.3M
William ChristieCranberry Township$5.2M
Carl RegilloPlymouth Meeting$3.2M
Erik KrugerKingston$3M
Sunir GargPlymouth Meeting$2M
Allen ChiangPlymouth Meeting$1.6M
Julia HallerPhiladelphia$1.5M
Mitchell FinemanPlymouth Meeting$1.3M
Allen HoPlymouth Meeting$1.3M
Brandon AyresBala Cynwyd$1.3M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →